Clinical trial Recruiting at 1 site Observational Ages 18 and up Women only

Study on the effects of antipsychotic medications during pregnancy on mothers and infants

Official title: Developmental Effects of Antenatal Exposure to Antipsychotics

Run by Icahn School of Medicine at Mount Sinai · NCT06049953 · Data updated 2026-11-12

This study looks at how taking antipsychotic medications during pregnancy affects both mothers with severe mental illness and the development of their babies.

More Pregnancy trials

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment74 (estimated)
SponsorIcahn School of Medicine at Mount Sinai
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedSeptember 29, 2023
Main results expectedJanuary 1, 2028
Study endsJanuary 1, 2028
Registry record updatedJune 22, 2026
Trial IDNCT06049953 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are pregnant individuals diagnosed with severe mental illnesses such as psychotic disorders or bipolar disorder.

Probably not a fit

Patients with active substance use disorders during pregnancy or those unable to provide informed consent may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to investigate the psychiatric course of pregnant individuals with severe mental illness and the developmental outcomes of their infants. It compares those treated with antipsychotics to those receiving other medications or no medication at all. Participants will undergo psychiatric interviews, complete questionnaires, and provide blood samples at delivery, while their infants will be evaluated for behavior and undergo EEG procedures. The study seeks to understand the risks of psychiatric relapse and differences in pregnancy and neonatal health outcomes based on medication exposure.

Why it matters

Potential benefit: If successful, this study could provide critical insights into the safety and effects of antipsychotic medications during pregnancy, potentially guiding treatment decisions for pregnant individuals with severe mental illness.

How similar studies have gone: While limited data exists on developmental outcomes associated with antenatal exposure to antipsychotics, this study aims to fill a significant gap in understanding, making it a novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pregnant
* Severe mental illness, including:

  * Psychotic disorder (affective and nonaffective)
  * Bipolar disorder
  * History of psychiatric hospitalization, regardless of diagnosis
* Able to complete study interviews and measures in English, Dutch, or Spanish

Exclusion Criteria:

* Active substance use disorder in pregnancy
* Insufficiently high-functioning to provide full informed consent and/or participate in study procedures

Where it's running

  • Icahn School of Medicine at Mount Sinai
    New York, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.